These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27264413)

  • 1. Effects of 4 Statins on Regression of Coronary Plaque in Acute Coronary Syndrome.
    Matsushita K; Hibi K; Komura N; Akiyama E; Maejima N; Iwahashi N; Tsukahara K; Kosuge M; Ebina T; Sumita S; Umemura S; Kimura K
    Circ J; 2016 Jun; 80(7):1634-43. PubMed ID: 27264413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study).
    Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    J Am Coll Cardiol; 2009 Jul; 54(4):293-302. PubMed ID: 19608026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sitagliptin on plaque changes in coronary artery following acute coronary syndrome in diabetic patients: The ESPECIAL-ACS study.
    Kuramitsu S; Miyauchi K; Yokoi H; Suwa S; Nishizaki Y; Yokoyama T; Nojiri S; Iwabuchi M; Shirai S; Ando K; Okazaki S; Tamura H; Watada H; Daida H
    J Cardiol; 2017 Jan; 69(1):369-376. PubMed ID: 27641967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial).
    Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    Circ J; 2010 Jun; 74(6):1165-74. PubMed ID: 20467151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
    Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome.
    Dohi T; Miyauchi K; Okazaki S; Yokoyama T; Ohkawa R; Nakamura K; Yanagisawa N; Tsuboi S; Ogita M; Yokoyama K; Kurata T; Yatomi Y; Daida H
    Atherosclerosis; 2011 Dec; 219(2):907-12. PubMed ID: 22024276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clustering of metabolic syndrome components attenuates coronary plaque regression during intensive statin therapy in patients with acute coronary syndrome: the JAPAN-ACS subanalysis study.
    Takashima H; Ozaki Y; Morimoto T; Kimura T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Daida H; Mizuno T; Asai K; Kuroda Y; Kosaka T; Kuhara Y; Kurita A; Maeda K; Amano T; Matsuzaki M;
    Circ J; 2012; 76(12):2840-7. PubMed ID: 22972364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Ezetimibe-Statin Combination Therapy on Coronary Atherosclerosis in Acute Coronary Syndrome.
    Hibi K; Sonoda S; Kawasaki M; Otsuji Y; Murohara T; Ishii H; Sato K; Koshida R; Ozaki Y; Sata M; Morino Y; Miyamoto T; Amano T; Morita S; Kozuma K; Kimura K; Fujiwara H;
    Circ J; 2018 Feb; 82(3):757-766. PubMed ID: 29212965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study.
    Arai H; Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    J Atheroscler Thromb; 2010 Oct; 17(10):1096-107. PubMed ID: 20675955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of non-culprit plaque regression following acute coronary syndrome: A serial intravascular ultrasound study.
    Endo H; Dohi T; Miyauchi K; Kuramitsu S; Kato Y; Okai I; Yokoyama M; Yokoyama T; Ando K; Okazaki S; Shimada K; Suwa S; Daida H
    J Cardiol; 2019 Aug; 74(2):102-108. PubMed ID: 30737184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study.
    Ohashi T; Shibata R; Morimoto T; Kanashiro M; Ishii H; Ichimiya S; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura T; Daida H; Murohara T; Matsuzaki M
    Atherosclerosis; 2010 Sep; 212(1):237-42. PubMed ID: 20684825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary plaque progression of non-culprit lesions after culprit percutaneous coronary intervention in patients with moderate to advanced chronic kidney disease: intravascular ultrasound and integrated backscatter intravascular ultrasound study.
    Kashiyama K; Sonoda S; Muraoka Y; Suzuki Y; Kamezaki F; Tsuda Y; Araki M; Tamura M; Takeuchi M; Abe H; Okazaki M; Fujino Y; Otsuji Y
    Int J Cardiovasc Imaging; 2015 Jun; 31(5):935-45. PubMed ID: 25724567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels.
    Wakabayashi K; Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Miyake S; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Suzuki H; Michishita I;
    J Atheroscler Thromb; 2016 Sep; 23(9):1055-66. PubMed ID: 27040362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
    Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
    J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of serum lipoprotein (a) level on coronary plaque progression and cardiovascular events in statin-treated patients with acute coronary syndrome: a yokohama-acs substudy.
    Matsushita K; Hibi K; Komura N; Kimura Y; Matsuzawa Y; Konishi M; Maejima N; Iwahashi N; Kosuge M; Ebina T; Tamura K; Kimura K
    J Cardiol; 2020 Jul; 76(1):66-72. PubMed ID: 32037254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome--subanalysis of the JAPAN-ACS study.
    Ogita M; Miyauchi K; Morimoto T; Daida H; Kimura T; Hiro T; Nakagawa Y; Yamagishi M; Ozaki Y; Matsuzaki M
    Atherosclerosis; 2013 Jan; 226(1):275-80. PubMed ID: 23159100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of statin therapy on plaque regression following acute coronary syndrome: a meta-analysis of prospective trials.
    Tang X; Yang Y; Luo S; Zhao Y; Lu C; Luo Y; Zhang F; Xiao H
    Coron Artery Dis; 2016 Dec; 27(8):636-649. PubMed ID: 27388482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Water- and Lipid-Soluble Statins on Nonculprit Lesions in Patients with Acute Coronary Syndrome.
    Ishikawa Y; Itoh T; Satoh M; Fusazaki T; Sugawara S; Nakajima S; Nakamura M; Morino Y
    Int Heart J; 2018 Jan; 59(1):27-34. PubMed ID: 29279527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy of eicosapentaenoic acid and pitavastatin for coronary plaque regression evaluated by integrated backscatter intravascular ultrasonography (CHERRY study)-rationale and design.
    Watanabe T; Miyamoto T; Miyasita T; Shishido T; Arimoto T; Takahashi H; Nishiyama S; Hirono O; Matsui M; Sugawara S; Ikeno E; Miyawaki H; Akira F; Kubota I
    J Cardiol; 2014 Sep; 64(3):236-9. PubMed ID: 24503140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.